At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
Brachytherapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase II Study of Dynamic Intraoperative Dosimetry for Prostate Brachytherapy Using Registered Fluoroscopy and Ultrasound
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins·interventional·Posted Aug 26, 2014·Updated Mar 13, 2023
In Brief
A clinical study evaluating Brachytherapy for Prostate Cancer and Adenocarcinoma of the Prostate. Completed, enrolled 45 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the performance of a system of intraoperative dynamic dosimetry during prostate seed implantation (brachytherapy) including its new elements, to evaluate and refine technical methods of using the system, as well as confirm its performance and accuracy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer, Adenocarcinoma of the Prostate
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 2014
Enrollment StartOct 2014
Primary CompletionDec 2016
Study CompletionFeb 2023
TodayJul 2026
First PostedAug 26, 2014
Enrollment StartOct 1, 2014
Primary CompletionDec 1, 2016
Study CompletionFeb 28, 2023
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 11.8 years ago
Interventions
Brachytherapyradiation